Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; none of the 8 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Diabetes mellitus is a growing cause of disease burden globally. Its management is multifaceted, and adherence to pharmacotherapy is known to play a significant role in glycaemic control. Data on medication adherence among affected patients is unknown in Cameroon. In this study, the level of adherence and factors influencing non-adherence to antidiabetic medication among patients with type-2 diabetes was assessed. METHODS: A hospital-based cross-sectional study among adult patients receiving care in the diabetic clinics of the Limbe and Bamenda Regional Hospitals in Cameroon was conducted. Medication adherence was assessed using the Medication Compliance Questionnaire (MCQ). Factors associated with non-adherence to medication were determined using basic and adjusted multivariable logistic regression models. RESULTS: A total of 195 patients with type 2 diabetes were recruited. The prevalence of non-adherence to medication was 54.4% [95% confidence interval (CI): 47.1-61.5%]. In multivariable analysis, age > 60 years (aO.R. = 0.48, 95% CI: 0.25-0.94), alcohol consumption (aO.R. = 2.13, 95% CI: 1.10-4.14) and insulin alone therapy (aO.R. = 2.85, 95% CI: 1.01-8.08) were associated with non-adherence. Patients attributed their non-adherence to forgetfulness (55.6%), lack of finances (38.2%) and disappearance of symptoms (14.2%). CONCLUSIONS: Adherence to anti-diabetic medication is poor in this study with more than half of participants being non-adherent. Urgent interventions are required to tackle this problem in combined efforts to stem this looming diabetes epidemic.
Overview
CoChat Summary
## TL;DR
This hospital-based cross-sectional study in two regional hospitals in Cameroon found that 54.4% of 195 adults with type 2 diabetes were non-adherent to antidiabetic medication. Non-adherence was associated with age > 60 years, alcohol consumption, and insulin-only therapy, with forgetfulness and lack of money the most common reasons reported.
## Key findings
- Among 195 patients, 106 were non-adherent, giving a prevalence of 54.4% (95% CI: 47.1–61.5%).
- In multivariable analysis, age > 60 years was associated with lower odds of non-adherence (aOR = 0.48, 95% CI: 0.25–0.94), while alcohol consumption (aOR = 2.13, 95% CI: 1.10–4.14) and insulin-only therapy (aOR = 2.85, 95% CI: 1.01–8.08) were associated with higher odds.
- The most common self-reported reasons for non-adherence were forgetfulness (55.6%), lack of finances (38.2%), and disappearance of symptoms (14.2%).
- The sample was mostly women (70.3%), with mean age 60.5 ± 13.6 years; 62.6% had hypertension and 30.3% were on at least insulin therapy.
## Methods
- Hospital-based cross-sectional study conducted from August to September 2016 in diabetic clinics of Bamenda Regional Hospital and Limbe Regional Hospital in Cameroon.
- Consecutive sampling of 195 adults (>18 years) with confirmed type 2 diabetes receiving treatment; data included socio-demographics, comorbidities, duration of diabetes, medication type, and alcohol/smoking status.
- Medication adherence was measured with the validated Medication Compliance Questionnaire (MCQ); associations with non-adherence were tested using bivariate and multivariable logistic regression in Stata, with significance set at p < 0.05.
## Limitations
- The paper states that adherence was self-reported, which is liable to recall bias and may overestimate adherence; the authors note the non-adherence estimate is likely conservative.
- The cross-sectional design limits temporality and causal inference, allowing only associations.
- The consecutive convenience sampling may have introduced selection bias, and the small sample size limits generalizability and motivated the need for larger studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 4 Not checked · 12 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The prevalence of non-adherence to medication was 54.4% [95% confidence interval (CI): 47.1–61.5%].”
- Also stated in: § Prevalence and reasons for non-adherence to antidiabetic medication · plain
“Overall, 106 participants were non-adherent to antidiabetic medications with a prevalence of 54.4% (95% confidence interval [CI]: 47.1–61.5%).”
- Also stated in: § Discussion · plain
“More than half (54.4%) of our study participants were non-adherent to their diabetic medication.”
§ Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon > Abstract > Results
plainn = 106- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Prevalence and reasons for non-adherence to antidiabetic medication · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In multivariable analysis, age > 60 years (aO.R. = 0.48, 95% CI: 0.25–0.94), alcohol consumption (aO.R. = 2.13, 95% CI: 1.10–4.14) and insulin alone therapy (aO.R. = 2.85, 95% CI: 1.01–8.08) were associated with non-adherence.”
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
“In multivariable analysis, participants who were aged > 60 years (adjusted odds ratio (aO.R.) = 0.48; 95% CI: 0.25–0.94, p = 0.02), participants who consumed alcohol (aO.R. = 2.13; 1.10–4.14, p = 0.04) and participants on insulin therapy (aO.R. = 2.85; 1.01–8.08, p = 0.04) were more likely to be non-adherent to their antidiabetic medication (Table 4).”
- Also stated in: § Discussion · plain
“Patients on insulin therapy alone were twice as likely to be non-adherent compared to participants on oral hypoglycaemic agents (OHA).”
§ Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon > Abstract > Results
plainstates an associationn = 195 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In multivariable analysis, age > 60 years (aO.R. = 0.48, 95% CI: 0.25–0.94), alcohol consumption (aO.R. = 2.13, 95% CI: 1.10–4.14) and insulin alone therapy (aO.R. = 2.85, 95% CI: 1.01–8.08) were associated with non-adherence.”
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
“In multivariable analysis, participants who were aged > 60 years (adjusted odds ratio (aO.R.) = 0.48; 95% CI: 0.25–0.94, p = 0.02), participants who consumed alcohol (aO.R. = 2.13; 1.10–4.14, p = 0.04) and participants on insulin therapy (aO.R. = 2.85; 1.01–8.08, p = 0.04) were more likely to be non-adherent to their antidiabetic medication (Table 4).”
- Also stated in: § Discussion · plain
“A two-fold increase in non-adherence was associated with alcohol consumption.”
§ Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon > Abstract > Results
plainstates an associationn = 195 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forgetfulness (30.2%), lack of finances (17.4%), disappearance of symptoms (7.7%) and being too busy (7.7%) were some of the main reasons highlighted by participants for non-adherence to their medication.”
- Also stated in: § Discussion · plain
“Forgetfulness, lack of finances, disappearance of symptoms and being too busy were the most frequent reasons given by participants as reasons for their non-adherence to medication.”
§ Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon > Results > Prevalence and reasons for non-adherence to antidiabetic medication
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In multivariable analysis, age > 60 years (aO.R. = 0.48, 95% CI: 0.25–0.94), alcohol consumption (aO.R. = 2.13, 95% CI: 1.10–4.14) and insulin alone therapy (aO.R. = 2.85, 95% CI: 1.01–8.08) were associated with non-adherence.”
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
“In multivariable analysis, participants who were aged > 60 years (adjusted odds ratio (aO.R.) = 0.48; 95% CI: 0.25–0.94, p = 0.02), participants who consumed alcohol (aO.R. = 2.13; 1.10–4.14, p = 0.04) and participants on insulin therapy (aO.R. = 2.85; 1.01–8.08, p = 0.04) were more likely to be non-adherent to their antidiabetic medication (Table 4).”
- Also stated in: § Discussion · plain
“In multipredictor analysis, patients aged more than 60 years had a 52% significantly lower odds of being non-adherent to their medication compared to those less than 60 years.”
§ Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon > Abstract > Results
plainstates an associationn = 195 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Factors associated with non-adherence to antidiabetic medication · plain
- It may state two separate claims as one. 9
- The quote only partly states this claim. 1
- Probably not a substantial claim. 3
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Rwegerera GM, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alex J Med. 2018;54(2):103–9.”
Cited work 10.1016/j.ajme.2017.01.005 · retracted 2019-08-27 · notice 10.1080/20905068.2019.1656866 · this paper published 2019-04-03
Citations
Cites
1 retracted
Rwegerera, G. M., Moshomo, T., Gaenamong, M., Oyewo, T. A., Gollakota, S., Mhimbira, F., Fadare, J. O., Godman, B., Meyer, J. C., & Rivera, Y. P. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.01.005 · Cited by 38
RetractedInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Self-citationHay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Global obesity: trends, risk factors and policy implications
Malik, V. S., Willett, W. C., & Hu, F. B. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.199 · Cited by 1,408
Cited by
Piragine, E., Petri, D., Martelli, A., Calderone, V., & Lucenteforte, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051981 · Cited by 148
Medication adherence and self-care behaviours among patients with type 2 diabetes mellitus in Ghana
Afaya, R. A., Bam, V. B., Azongo, T. B., Afaya, A., Amponsah, A. K., Ajusiyine, J. M., & Hamid, T. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237710 · Cited by 88
“It seems evident from the review of relevant literature that similar studies have been conducted in Europe [13], Middle East [8, 12], South Africa [14], East Africa [11, 10] with limited studies in the West African sub-region [8, 9].”
BackgroundResultInfluentialAzharuddin, M., Adil, M., Sharma, M., & Gyawali, B. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14717 · Cited by 76
Schäfermann, S., Neci, R., Ndze, E. N., Nyaah, F., Pondo, V. B., & Heide, L. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227515 · Cited by 44
“Notably, a 2019 survey indicated that high prices of medicines were a prominent cause for non-adherence among diabetes patients in two hospitals in Cameroon [37].”
BackgroundMannan, A., Hasan, M. M., Akter, F., Rana, M. M., Chowdhury, N. A., Rawal, L. B., & Biswas, T. (2021) · Global Health Action · doi:10.1080/16549716.2021.1872895 · Cited by 69
“We assessed the medication adherence using a self-reported, structured, eight-item questionnaire that has been validated in different study settings [19,20] with the following cutoff scores: >2 = low adherence, 1 or 2 = medium adherence, 0 = high adherence [21].”
Method
Metadata
- Authors
- Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F.
- Affiliations
- Université Libre de Bruxelles (BE)
- University of Douala (CM)
- University of Buea (CM)
- Liverpool School of Tropical Medicine (GB)
- Venue
- BMC Endocrine Disorders
- Published
- 2019-04-03
- Volume
- 19
- Issue
- 1
- Pages
- 35-35
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC6446302
- OpenAlex
- W2942460647
- Cited by
- 147
- References
- 44
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 19 · 2023: 31 · 2022: 23 · 2021: 26 · 2020: 8 · 2019: 6
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Griffith Research Online (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Keywords
- medication adherence, antidiabetic drugs, type 2 diabetes, non-adherence factors, alcohol consumption, insulin monotherapy, old age, forgetfulness
- MeSH terms
- Assessment of Medication Adherence, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. https://app.cochat.ai/papers/10.1186/s12902-019-0360-9
- The paper
- Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. (2019). Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-019-0360-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.